InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by WILLITS ALAN D, Vice-Président Exécutif, Responsable Commercial. Officer active across 1 companies, notably S&W Seed Co. Cumulatively, 4 filings have been recorded. The latest transaction was filed on 15 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
022,799 shares0
Common Stock
SEC:0001209191-21-070308·
022,799 shares0
Common Stock
SEC:0001209191-21-070308:0·
€862,699366,300 shares@ €2.35525.53% mcap100.0% of flow
Common Stock
SEC:0001209191-21-060815·
€862,699366,300 shares@ €2.35525.53% mcap50.0% of flow
Common Stock
SEC:0001209191-21-060815:0·
4 of 4 declarations
About WILLITS ALAN D
Mark Neumann serves as Executive Vice President, Chief Commercial Officer at Intra-Cellular Therapies, Inc. In this role, he oversees the company's commercial activities, including sales development and marketing. Mark plays a key role in implementing commercial strategies that support the company's growth.
